Delocalized π36 Bond in OX2 (X=Halogen) Molecules

被引:2
|
作者
Tang, Yi-han [1 ]
Yang, Pu [2 ]
Chen, Meng-yuan [2 ]
Wang, Yu-ru [1 ]
Wang, Jia-xin [2 ]
Xu, Jia-wei [2 ,3 ]
机构
[1] Changzhou Univ, Sch Petrochem Engn, Changzhou 213164, Peoples R China
[2] Nanjing Normal Univ, Sch Chem & Mat Sci, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Jiangsu Key Lab New Power Batteries, Nanjing 210023, Peoples R China
[3] Nanjing Normal Univ, Jiangsu Key Lab Numer Simulat Large Scale Complex, Nanjing 210023, Peoples R China
关键词
Theoretical and computational chemistry; Valence shell electron pair repulsion theory; Delocalized pi bond; Delocalization stabilization energy; Dihalogen monoxide; CONSISTENT BASIS-SETS; ZETA VALENCE QUALITY; THERMAL-DECOMPOSITION; TRIMETHYLENEMETHANE; GEOMETRY;
D O I
10.1063/1674-0068/cjcp2006101
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
OX2 (X=halogen) molecules was studied theoretically. Calculation results show that delocalized pi(6)(3) bonds exist in their electronic structures and O atoms adopt the sp(2) type of hybridization, which violates the prediction of the valence shell electron pair repulsion theory of sp a type. Delocalization stabilization energy is proposed to measure the contribution of delocalized pi(6)(3) bond to energy decrease and proves to bring extra-stability to the molecule. These phenomena can be summarized as a kind of coordinating effect.
引用
收藏
页码:542 / 550
页数:9
相关论文
共 50 条
  • [1] Distribution of OX2 antigen and OX2 receptor within retina
    Dick, AD
    Broderick, C
    Forrester, JV
    Wright, GJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (01) : 170 - 176
  • [2] OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
    Thompson, Miles D.
    Xhaard, Henri
    Sakurai, Takeshi
    Rainero, Innocenzo
    Kukkonen, Jyrki P.
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [3] BOND ENERGIES OF HALOGEN MOLECULES
    CALDOW, GL
    COULSON, CA
    TRANSACTIONS OF THE FARADAY SOCIETY, 1962, 58 (472): : 633 - &
  • [4] Characterization of a minimal promoter for human OX2
    Chen, ZQ
    Marsden, P
    Gorczynski, R
    FASEB JOURNAL, 2001, 15 (04): : A698 - A698
  • [5] Biochemical and Electrophysiological Characterization of Almorexant, a Dual Orexin 1 Receptor (OX1)/Orexin 2 Receptor (OX2) Antagonist: Comparison with Selective OX1 and OX2 Antagonists
    Malherbe, Pari
    Borroni, Edilio
    Pinard, Emmanuel
    Wettstein, Joseph G.
    Knoflach, Frederic
    MOLECULAR PHARMACOLOGY, 2009, 76 (03) : 618 - 631
  • [6] Distinct recognition of OX1 and OX2 receptors by orexin peptides
    Ammoun, S
    Holmqvist, T
    Shariatmadari, R
    Oonk, HB
    Detheux, M
    Parmentier, M
    Åkerman, KEO
    Kukkonen, JP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02): : 507 - 514
  • [7] Cloning of the human MRC OX2 promoter region
    Chen, Z
    Marsden, PA
    Gorczynski, RM
    FASEB JOURNAL, 2000, 14 (06): : A1069 - A1069
  • [8] Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
    Turku, Ainoleena
    Borrel, Alexandre
    Leino, Teppo O.
    Karhu, Lasse
    Kukkonen, Jyrki P.
    Xhaard, Henri
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8263 - 8275
  • [9] LYSOTYPIE DES PROTEUS OX19 OXK OX2 ET OXL
    VIEU, JF
    CAPPONI, M
    ANNALES DE L INSTITUT PASTEUR, 1965, 108 (01): : 103 - &
  • [10] Macrophage regulation by the B7.1/2 homologue OX2?
    Hoek, RM
    Ruuls, SR
    Homola, ME
    Brown, M
    Streit, WJ
    Lemckert, FA
    Barclay, AN
    Sedgwick, JD
    FASEB JOURNAL, 2000, 14 (06): : A1232 - A1232